UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Chubb
CB
|
+$745M |
| 2 |
Spotify
SPOT
|
+$727M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$689M |
| 4 |
Meta Platforms (Facebook)
META
|
+$680M |
| 5 |
NXP Semiconductors
NXPI
|
+$573M |
Top Sells
| 1 |
Prologis
PLD
|
+$1.33B |
| 2 |
Union Pacific
UNP
|
+$1.2B |
| 3 |
Equinix
EQIX
|
+$929M |
| 4 |
Broadcom
AVGO
|
+$805M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$685M |
Sector Composition
| 1 | Technology | 37.43% |
| 2 | Financials | 12.57% |
| 3 | Healthcare | 10.57% |
| 4 | Consumer Discretionary | 10.41% |
| 5 | Communication Services | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Schneider National
SNDR
$6.47B
| $3.56M | ﹤0.01% |
134,049
-26,969
| -17% | -$637K |
|
1627
Goosehead Insurance
GSHD
$1.19B
| $3.55M | ﹤0.01% |
48,231
+378
| +0.8% | +$26.9K |
|
1628
FB Financial Corp
FBK
$2.92B
| $3.55M | ﹤0.01% |
63,594
+3,522
| +6% | +$197K |
|
1629
Donnelley Financial Solutions
DFIN
$1.17B
| $3.55M | ﹤0.01% |
75,998
+1,543
| +2% | +$74.6K |
|
1630
ARS Pharmaceuticals
SPRY
$756M
| $3.55M | ﹤0.01% |
304,445
-30,703
| -9% | -$299K |
|
1631
Array Technologies
ARRY
$966M
| $3.55M | ﹤0.01% |
384,533
+20,406
| +6% | +$175K |
|
1632
Kosmos Energy
KOS
$1.48B
| $3.53M | ﹤0.01% |
3,893,350
+317,608
| +9% | +$419K |
|
1633
Establishment Labs
ESTA
$2.55B
| $3.52M | ﹤0.01% |
48,326
-2,777
| -5% | -$168K |
|
1634
Encore Capital Group
ECPG
$1.92B
| $3.51M | ﹤0.01% |
64,600
-3,557
| -5% | -$171K |
|
1635
Werner Enterprises
WERN
$2.69B
| $3.51M | ﹤0.01% |
116,994
+5,802
| +5% | +$159K |
|
1636
Centuri Holdings
CTRI
$2.65B
| $3.5M | ﹤0.01% |
138,611
+53,171
| +62% | +$1.19M |
|
1637
RXO
RXO
$4.62B
| $3.5M | ﹤0.01% |
276,659
+32,833
| +13% | +$484K |
|
1638
Tennant Co
TNC
$1.45B
| $3.48M | ﹤0.01% |
47,156
-99
| -0.2% | -$7.57K |
|
1639
Vericel Corp
VCEL
$2.35B
| $3.47M | ﹤0.01% |
96,333
+2,671
| +3% | +$98.1K |
|
|
CWEN.A
1640
DELISTED
Clearway Energy Class A
CWEN.A
| $3.46M | ﹤0.01% |
110,226
-28,003
| -20% | -$876K |
|
1641
Clarivate
CLVT
$1.48B
| $3.45M | ﹤0.01% |
1,031,825
-27,316
| -3% | -$97.1K |
|
1642
Quaker Houghton
KWR
$2.6B
| $3.44M | ﹤0.01% |
25,017
-1,372
| -5% | -$185K |
|
1643
Arcus Biosciences
RCUS
$3.56B
| $3.43M | ﹤0.01% |
144,093
+56,322
| +64% | +$1.15M |
|
1644
Immunovant
IMVT
$7.96B
| $3.42M | ﹤0.01% |
134,441
+27,217
| +25% | +$607K |
|
1645
ACM Research
ACMR
$6.83B
| $3.39M | ﹤0.01% |
85,916
+13,249
| +18% | +$494K |
|
1646
Porch Group
PRCH
$1.5B
| $3.39M | ﹤0.01% |
371,106
+297,806
| +406% | +$3.59M |
|
1647
First Commonwealth Financial
FCF
$2.08B
| $3.38M | ﹤0.01% |
200,679
-10,571
| -5% | -$173K |
|
|
NXRT
1648
NexPoint Residential Trust
NXRT
$692M
| $3.38M | ﹤0.01% |
112,366
-11,892
| -10% | -$364K |
|
1649
Payoneer
PAYO
$2.4B
| $3.38M | ﹤0.01% |
601,421
-24,676
| -4% | -$143K |
|
1650
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $3.38M | ﹤0.01% |
+62,815
| New | +$3.41M |
|
Similar funds
